WordNet

small room in which a monk or nun lives (同)cubicle
a device that delivers an electric current as the result of a chemical reaction (同)electric cell
a room where a prisoner is kept (同)jail cell, prison cell
(biology) the basic structural and functional unit of all organisms; they may exist as independent units of life (as in monads) or may form colonies or tissues as in higher plants and animals
any small compartment; "the cells of a honeycomb"
a small unit serving as part of or as the nucleus of a larger political movement (同)cadre
of or relating to walls; "mural painting"
a painting that is applied to a wall surface (同)wall_painting

PrepTutorEJDIC

(刑務所の)『独房』;(修道院の)小さい独居室 / (ミツバチの)みつ房,巣穴 / 小さい部屋 / 『細胞』 / 電池 / 花粉室 / (共産党などの)細胞
壁の;壁に掛かった(描いた) / 壁画,天井画

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2015/10/27 16:44:51」(JST)

wiki en

The term mural cell refers generally to vascular smooth muscle cells and pericytes, both involved in the formation of normal vasculature and responsive to vascular endothelial growth factor (VEGF).^[1] The weakness and disorganization of tumor vasculature is partly due to the inability of tumors to recruit properly organized mural cells.^[2]

Mural cells have contractile function. As the progenitors of smooth muscle cells (SMCs) and pericytes, mural cells themselves derive from the mesenchyme. Invasive endothelial become surrounded by locally-derived mesenchymal cells, meaning the surrounding primordium itself contributes the mural cells to the developing vessels. This is advantageous as it can result in tissue-specific functional and regulatory properties of pericytes, and SMCs. In contrast, endothelial cells are thought to be of uniform origin.

References

^ Fujimoto, Akihisa, Onodera, Hisashi, Mori, Akira, Isobe, Naoki, Yasuda, Seiichi, Oe, Hideaki, Yonenaga, Yoshikuni, Tachibana, Tsuyoshi & Imamura, Masayuki (2004) Vascular endothelial growth factor reduces mural cell coverage of endothelial cells and induces sprouting rather than luminal division in an HT1080 tumour angiogenesis model. International Journal of Experimental Pathology 85 (6), 355-364.
^ Abramsson A, Berlin O, Papayan H, Paulin D, Shani M, Betsholtz C. (2002). Analysis of Mural Cell Recruitment to Tumor Vessels. Circulation 105:112.

This cell biology article is a stub. You can help Wikipedia by expanding it.

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 末梢性T細胞リンパ腫の初期治療 initial treatment of peripheral t cell lymphoma
2. 皮下蜂窩織炎様T細胞性リンパ腫の臨床症状、病理学的特徴、および診断 clinical manifestations pathologic features and diagnosis of subcutaneous panniculitis like t cell lymphoma
3. ALK陽性未分化大細胞型リンパ腫の臨床症状、病理学的特徴、および診断 clinical manifestations pathologic features and diagnosis of anaplastic large cell lymphoma alk positive
4. B細胞前リンパ球性白血病の臨床症状、病理学的特徴、および診断 clinical manifestations pathologic features and diagnosis of b cell prolymphocytic leukemia
5. びまん性大細胞型B細胞性リンパ腫の疫学、臨床症状、病理学的特徴、および診断 epidemiology clinical manifestations pathologic features and diagnosis of diffuse large b cell lymphoma

English Journal

The complex mural cell: Pericyte function in health and disease.

van Dijk CG1, Nieuweboer FE1, Pei JY1, Xu YJ1, Burgisser P2, van Mulligen E1, El Azzouzi H2, Duncker DJ3, Verhaar MC1, Cheng C4.
International journal of cardiology.Int J Cardiol.2015 Jul 1;190:75-89. doi: 10.1016/j.ijcard.2015.03.258. Epub 2015 Mar 20.
Pericytes are perivascular cells that can be distinguished from vascular smooth muscle cells by their specific morphology and expression of distinct molecular markers. Found in the microvascular beds distributed throughout the body, they are well known for their regulation of a healthy vasculature.
PMID 25918055

Enhanced Anti-Angiogenic Effect of Low Molecular Weight Heparin-Bile Acid Conjugates by Co-Administration of a Selective COX-2 Inhibitor.

Kim JY1, Chung SW, Kim SY, Byun Y.
Pharmaceutical research.Pharm Res.2015 Jul;32(7):2318-27. doi: 10.1007/s11095-015-1623-4. Epub 2015 Jan 15.
PURPOSE: To overcome definite limitations of angiogenesis inhibitors such as insufficient therapeutic efficacy as a single drug and resisting or conflicting effect under chronic treatment, it is required to develop a new regimen to improve the therapeutic effect.METHODS: The combination effect of a
PMID 25585956
PMID 25853910

Japanese Journal

がん幹細胞のニッチの形成と制御 (特集基礎から拓くDDS創薬フロンティア)

高倉伸幸
Drug delivery system : DDS : official Journal of the Japan Society of Drug Delivery System 27(1), 28-33, 2012-01
NAID 40019180123

三重複癌を呈した Granulocyte colony-stimulating factor (G-CSF) 産生肝原発腺扁平上皮癌の1例

入江孝延,竹田晃,高田良司,齋藤義修,藤永哲治,田中聡司,原田直毅,石井修二,西山範,鈴木貴弘,春名能通,伏見博彰,井上敦雄
日本消化器病學會雜誌 = The Japanese journal of gastro-enterology 108(2), 259-266, 2011-02-05
83歳男性．著明な白血球増多で入院．胸腹部CTと大腸内視鏡検査で肝癌，上行結腸癌，肺癌と診断，尿細胞診で膀胱癌が疑われ，血中G-CSFが高値であった．全身状態の悪化により第38病日に永眠された．剖検では，肝腺扁平上皮癌を認め，抗G-CSF抗体の免疫染色で陽性であった．他に上行結腸粘液癌・腺癌，膀胱尿路上皮癌も認めたが，G-CSF抗体で染色されなかった．肺扁平上皮癌も認めたが肝癌の転移と思われた．
NAID 10029388186